A role for transforming growth factor-β1 in the increased pneumonitis in murine allogeneic bone marrow transplant recipients with graft-versus- host disease after pulmonary herpes simplex virus type 1 infection

Blood

Volumn 92, Issue 7, 1998, Pages 2581-2589

  Adler, Heiko ^b   Beland, Janice L ^b   Kozlow, Wende ^b   Del Pan, Nadia C ^b   Kobzik, Lester ^b   Rimm, Ilonna J ^a  

^a PFIZER INC   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ALLOGENIC BONE MARROW TRANSPLANTATION; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; EXPERIMENTAL INFECTION; FEMALE; GRAFT VERSUS HOST REACTION; HERPES; HISTOPATHOLOGY; LUNG LAVAGE; LYMPHOCYTE COUNT; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PNEUMONIA; PRIORITY JOURNAL; VIRUS LOAD;

EID: 0032190170     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.7.2581     Document Type: Article

References (46)

1. Meyers JD: Infection in bone marrow transplant recipients. Am J Med 81:27, 1986
2. Hoyle C, Goldman JM: Life-threatening infections occurring more than 3 months after BMT. Bone Marrow Transplant 14:247, 1994
3. Ochs L, Shu XO, Miller J. Enright H, Wagner J, Filipovich A, Miller W, Weisdorf D: Late infections after allogeneic bone marrow transplantation: Comparison of incidence in related and unrelated donor transplant recipients. Blood 86:3979, 1995
4. Adler H, Beland JL, Del-Pan NC, Kobzik L, Brewer JP, Martin TR, Rimm U: Suppression of herpes simplex virus type 1 (HSV-1)induced pneumonia in mice by inhibition of inducible nitric oxide synthase (iNOS, NOS2). J Exp Med 185:1533, 1997
5. Shanley JD, Pesanti EL: The relation of viral replication to interstitial pneumonitis in murine cytomegalovirus lung infection. J Infect Dis 151:454, 1985
6. Grundy JE, Shanley JD. Griffiths PD: Is cytomegalovirus interstitial pneumonitis in transplant patients an immunopathological condition? Lancet 2:996, 1987
7. Kohl S: Herpes simplex virus immunology: Problems, progress, and promises. J Infect Dis 152:435, 1985
8. Mester JC, Rouse BT: The mouse model and understanding immunity to herpes simplex virus. Rev Infect Dis 13:935, 1991
9. Nash AA, Leung KN, Wildy P: The T-cell-mediated immune response of mice to herpes simplex virus, in Roizman B, Lopez C (eds): The Herpesviruses. New York, NY, Plenum, 1985, p 87
10. Wu L, Morahan PS: Macrophages and other nonspecific defenses: Role in modulating resistance against herpes simplex virus. Curr Top Microbiol Immunol 179:89, 1992
11. Croen KD: Evidence for an antiviral effect of nitric oxide. J Clin Invest 91:2446. 1993
12. Karupiah G, Xie Q-W, Buller RML, Nathan C, Duarte C, MacMicking JD: Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase. Science 261:1445. 1993
13. Mercadal CM, Bouley DM, DeStephano D, Rouse BT: Herpetic stromal keratitis in the reconstituted scid mouse model. J Virol 67:3404, 1993
14. Shanley JD, Korngold R, Forman SJ: The effect of graft-versus-host disease in response to minor histocompatibility antigens on acute murine cytomegalovirus infection. Transplantation 56:487, 1993
15. Korngold R, Sprent J: Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. J Exp Med 148:1687, 1978
16. Cooke KR, Kobzik L, Martin TR, Brewer J, Delmonte J, Crawford JM, Ferrara JLM: An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I, The roles of minor H antigens and endotoxin. Blood 8:3230, 1996
17. Hughes RG, Munyon WH: Temperature-sensitive mutants of herpes simplex virus type 1 defective in lysis but not in transformation. J Virol 16:275, 1975
18. Nguyen LD, Knipe M, Finberg, RB: Mechanism of virus-induced Ig subclass shifts. J Immunol 152:478, 1994
19. Zollinger WD, Boslego JW; A general approach to standardization of the solid-phase radioimmunoassay for quantitation of class-specific antibodies. J Immunol Methods 46:129, 1981
20. Miller A, AI-Sabbagh A, Santos LMB, Das MP, Weiner HL: Epitopes of myelin basic protein that trigger TGF-β release after oral tolerization are distinct from encephalitogenic epitopes and mediate epitope-driven bystander suppression. J Immunol 151:7307, 1993
21. Ayala A, Meldrum DR, Perrin MM, Chaudry IH: The release of transforming growth factor-β following haemorrhage: Its role as a mediator of host immunosuppression. Immunology 79:479, 1993
22. Chen Y, Kuchroo VK, Inobe J-I, Hafler DA, Weiner HL: Regulatory T cell clones induced by oral tolerance: Suppression of autoimmune encephalomyelitis. Science 265:1237, 1994
23. Coutelier J-P, Van der Logt JTM, Heessen FWA, Warnier G, Van Snick J: IgG2a restriction of murine antibodies elicited by viral infections. J Exp Med 165:64, 1987
24. Mo XY, Sarawar SR, Doherty PC: Induction of cytokines in mice with parainfluenza pneumonia. J Virol 69: 1288, 1995
25. Ferrara JLM, Cooke KR, Pan L, Krenger W: The immunopathophysiology of acute graft-versus-host-disease. Stem Cells 14:473, 1996
26. Doukas MA, Gailicchio VSL: Cytokine modulation of radiation injury, in Aggarwal BB, Puri RK, (eds): Human Cytokines: Their Role in Disease and Therapy. Cambridge, UK, Blackwell Scientific, 1995, p 565
27. Piguet PF, Grau GE, Collart MA, Vassalli P, Kapanci Y: Pneumopathies of the graft-versus-host reaction. Alveolitis associated with an increased level of tumor necrosis factor mRNA and chronic interstitial pneumonitis. Lab Invest 61:37, 1989
28. Shanley JD, Via CS, Sharrow SO, Shearer GM: Interstitial pneumonitis during murine cytomegalovirus infection and graft-versus-host reaction. Characterization of bronchoalveolar lavage cells. Transplantation 44:658, 1987
29. Via CS, Shanley JD, Weatherly BR, Lang P, Shearer GM: Altered threshold for the induction of graft-versus-host immunodeficiency following murine cytomegalovirus infection. Host and donor contributions. Transplantation 46:298, 1988
30. Grundy JE, Shanley JD, Shearer GM: Augmentation of graft-versus-host reaction by cytomegalovirus infection resulting in interstitial pneumonitis. Transplantation 39:548, 1985
31. Cray C, Levy RB: The presence of infectious virus but not conventional antigen can exacerbate graft-versus-host reactions. Scand J Immunol 32: 177, 1990
32. Via CS, Shanley JD, Shearer GM: Synergistic effect of murine cytomegalovirus on the induction of acute graft-vs-host disease involving MHC class I differences only. J Immunol 145:3283, 1990
33. Levy RB, Jones M, Cray C: HSV-1 enhances GvHR-associated parent anti-F1 alloreactivity in vivo and in vitro. Cell Immunol 129:1, 1990
34. Appleton AL, Sviland L: Pathogenesis of GVHD: Role of herpes viruses. Bone Marrow Transplant 11:349, 1993
35. Wahl SM: Transforming growth factor beta (TGF-β) in inflammation: A cause and a cure. J Clin Immunol 12:61, 1992
36. Poli GA, Kinter L, Justement JS, Bressler P, Kehrl JH, Fauci AS: Transforming growth factor β suppresses human immunodeficiency virus expression and replication in infected cells of the monocyte/ macrophage lineage, J Exp Med 173:589, 1991
37. Schultz-Cherry S, Hinshaw VS: Influenza virus neuraminidase activates latent transforming growth factor β. J Virol 70:8624, 1996
38. Ding A, Nathan CF, Graycar J, Derynck R, Sruehr DJ, Srimal S: Macrophage deactivating factor and transforming growth factors-betal, -beta2, and -beta3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-gamma. J Immunol 145:940, 1990
39. Hull HF, Blumhagen JD, Benjamin D, Corey L: Herpes simplex viral pneumonitis in childhood. J Pediatr 104:211, 1984
40. Benjamin DR: Herpes simplex tracheobronchitis and pneumonitis. Pediatr Pathol 9:773, 1989
41. Suzuki M, Suzuki Y, Ikeda H, Koike M, Nomura M, Tamura J, Sato S, Hotta Y, Itoh G: Apoptosis of murine large intestine in acute graft-versus-host disease after allogeneic bone marrow transplantation across minor bistocompatibility barriers. Transplantation 57:1284, 1994
42. Quabeck K: The lung as a critical organ in marrow transplantation. Bone Marrow Transplant 14:S19, 1994
43. Mowat AM, Garside P, Fitton LA, Higley HR, Carlino JA: Regulatory activity of endogenous and exogenous transforming growth factor β in experimental intestinal immunopathology. Growth Factors 13:75, 1996
44. Su HC, Leite-Morris KA, Braun L, CA Biron: A role for transforming growth factor-βl in regulating natural killer cell and T lymphocyte proliferative responses during acute infection with lymphocytic choriomeningitis virus. J Immunol 147:2717, 1991
45. Su HC, Ishikawa R, Biron CA: Transforming growth factor-β expression and natural killer cell responses during virus infection of normal, nuDE, and SCID mice. J Immunol 151:4874, 1993
46. Garside P, Hutton AK, Severn A, Liew FY, Mowat AM: Nitric oxide mediates intestinal pathology in graft-versus-host disease. Eur J Immunol 22:2141, 1992